Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betamethasone for Thyroid Eye Disease-Related Upper Eyelid Retraction
NCT07866261Not yet recruiting
- Sponsor
- Assiut University
- Start
- Oct 2026
- Primary completion
- Oct 2027
01
Overview
Randomised, double-blind trial of betamethasone in thyroid eye disease (TED) (2 arms), sponsored by Assiut University. Primary endpoint: Change in Margin Reflex Distance 1 at 3 months. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
betamethasone
03
Conditions
thyroid eye disease (TED)
Beyond the preview
Go deeper on NCT07866261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07866261.